Man Group PLC Amphastar Pharmaceuticals, Inc. Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$38.65 - $43.48 $339,192 - $381,580	8,776 New	8,776 $351,000
Q4 2018 Feb 14, 2019	SELL	$17.72 - $22.51 $326,951 - $415,332	-18,451 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.39 - $19.38 $100,896 - $127,055	6,556 Added 55.12%	18,451 $355,000
Q2 2018 Aug 14, 2018	BUY	$14.63 - $19.6 $174,023 - $233,142	11,895 New	11,895 $182,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.